Orphan drugs are specific
pharmaceutical agents which are developed for treatment of orphan or rare
diseases. Orphan disease, according to laws of various countries, may include
medical conditions which have low prevalence, i.e. affects less than 200,000 persons
(U.S.), or 50,000 (Japan). Expiring patents of blockbuster drugs, drying
pipelines, stringent regulations across the globe, has encouraged the
pharmaceutical industries to shift the focus to a new business model that
includes niche busters or orphan drugs.
Currently, around 7,000 diseases are
recognized as orphan and around 250 new diseases are added to the list every
year. Orphan drug laws introduced and implemented in countries such as the
U.S., Japan, Singapore, Australia, and the European Union, have stimulated the
orphan drug market and shifted the focus of pharmaceutical companies towards
incentives on developing orphan drugs. The orphan drugs market currently forms
around six percent of the total pharmaceutical market. However, this market is
expected to register double digit growth to outshine the mainstream drugs
market in the near future.
Orphan drugs market will be driven
by the R&D benefits or grants availed, FDA fee waiver benefits, and shorter
development timelines along with favorable reimbursement, prolonged
exclusivity, premium pricing and fewer hurdles for getting approval of the
drug. However, the market confronts the challenge of locating or recruiting
patient for trials. Nevertheless, the orphan drug market is expected to
maintain a competitive edge over the traditional drug model.
Read
the Complete Report @ http://www.industrymonitor.co/report/169893-orphan
Some of the major players in the
orphan drug market include Pfizer, Genentech, Abbott Laboratories, Amgen, Inc.,
Sanofi Aventis, Janssen Biotech, Inc. among others.
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review of
micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis.
Hemendra Pratap
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
sales@IndustryMonitor.co
Website: http://www.industrymonitor.co/
Blog : http://hemendrapratap.wordpress.com/
0 comments:
Post a Comment
Note: only a member of this blog may post a comment.